Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relapse Prevention Therapy for Smokers With Schizophrenia
NCT01576640Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupropion in nicotine dependence, sponsored by Massachusetts General Hospital. Primary endpoint: 7-Day Point Prevalence Abstinence at Month 15. Started Dec 2005; status: terminated.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01576640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576640.